Navigation Links
MedInsights, Inc. Selects Douglas Young as VP - Sales & Product Development
Date:7/8/2008

Young to expand sales efforts for nationwide managed care services

NASHVILLE, Tenn., July 8 /PRNewswire/ -- MedInsights, Inc., a wholly owned subsidiary of GAB Robins North America, Inc., and a leading national managed care provider, announced that Douglas Young has joined its sales team as vice president of sales and product development.

"Doug will be a great asset to MedInsights as we expand our national sales efforts. We are excited to have Doug join our team and look forward to his success in MedInsights' continued growth," said Paula Woolworth, vice president -- MedInsights, Inc.

Mr. Young has more than 20 years of experience in the workers' compensation industry. He began his workers' compensation career with Gates, McDonald & Company serving as a claims adjuster, account executive, and regional sales manager. He subsequently held regional sales management positions with both the Frank Gates Companies and Acordia, Inc. Prior to joining MedInsights, Mr. Young served as national account manager and acquisition sales director with PMSI, Inc. Mr. Young received his bachelor's degree in business administration from Ohio State University and his MBA from Northern Kentucky University.

About MedInsights

MedInsights, Inc. provides medical cost-savings services for insurers and self-insured entities that have workers' compensation and other injury claims. Through integrated case management, medical cost containment and return-to-work services, MedInsights ensures injured employees receive appropriate treatment, while minimizing lost workdays and controlling health care costs. MedInsights provides the following managed care services to help clients reduce their loss costs and improve return-to-work statistics:

-- 24-hour Call and Intake Center

-- Field Case Management

-- Telephonic Case Management

-- Utilization Management

-- Pharmacy Benefits Management

-- Medical Bill Review

--
'/>"/>

SOURCE MedInsights, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Spanish Health Service Provider Selects Autonomy to Deliver Innovation Within Healthcare
2. Central Bucks Specialists, a Cardiology and Gastroenterology Multi-location Clinic, Selects MxSecure, Inc., Provider of Medical Transcription Services, as their Transcription Provider.
3. Award-Winning Massachusetts Hospital Selects MedQuist Enterprise Technology for Clinical Documentation and Speech Recognition
4. East Jefferson General Hospital Selects Allscripts Electronic Health Record, Offers Free Electronic Prescribing for Affiliated New Orleans-Area Physicians
5. The University of Toledo selects SXC Health Solutions (informedRx) to provide pharmacy benefit management services
6. Hoag Memorial Hospital Presbyterian Selects Allscripts for Electronic Health Record Subsidy Program
7. District of Columbia Primary Care Association Selects Microsoft Amalga to Improve Patient Care for the Underserved
8. Martin Memorial Health Systems Selects Allscripts for Electronic Health Record and Practice Management
9. AHIP Selects HealthTrio to Join AHIP Solutions Program
10. Trinity Health System Selects Beryl as Preferred Provider to Enhance Telephone Customer Service
11. New West Health Services Selects Perot Systems Xcelys(TM) 5.0 Software
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3Sex based prenatal brain differences found 10503 1Sex based prenatal brain differences found 10503 2Bladder Problems May Often Be Related to Mental Health 59989 1Bladder Problems May Often Be Related to Mental Health 59989 2Why antidepressants dont work for so many 59985 1Why antidepressants dont work for so many 59985 2Why antidepressants dont work for so many 59985 3